logo
I was living with ALS symptoms for years before I was diagnosed in my 40s. The signs you shouldn't ignore — and the reality of living with a terminal illness

I was living with ALS symptoms for years before I was diagnosed in my 40s. The signs you shouldn't ignore — and the reality of living with a terminal illness

Yahoo17-05-2025
May is ALS Awareness Month — an important cause to Stephanie Thompson. The Ottawa-based mom was in her early 40s when she began noticing the first signs of amyotrophic lateral sclerosis (ALS). The now 44-year-old was experiencing 'weird muscle cramps' that would occur seemingly out of nowhere.
"It's normal to get cramps in your feet, and I had those too, so I didn't think much of it," she said in an interview with Yahoo Canada. "But then I'd be brushing my hair and my hand would seize up, clamping around the brush so tightly I had to pry my fingers loose.'
The cramping worsened over time to the point that she recalled not being able to lift her head from her pillow. Still, it would be two years before Thompson felt they were serious enough to see a doctor.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Contact a qualified medical professional before engaging in any physical activity, or making any changes to your diet, medication or lifestyle.
'My three boys — 15, 13, and 6 — took up a lot of time, and there was always something going on,' she explained. 'I kept putting [my health] on the back burner. But then I had this feeling — it can't be normal because it lasted too long.'
In September 2023, two years after she first began noticing symptoms, the cramps had progressed to the point where Thompson needed to brace herself to stand up. Her doctor referred her to a specialist for an Electromyography (EMG), a procedure that measures muscle and nerve function.
"My first EMG and physical exam showed weakness, but I didn't get the results then,' Thompson said.
Thompson was referred to a neurologist in December 2023 for more tests and a second EMG; a month later, she received an MRI. February brought more tests and another EMG. Five months after she visited her doctor for her symptoms she received the devastating diagnosis: she had ALS.
'I went to a very dark place where I couldn't function…,' she said. 'You think about your life, even just the day before the diagnosis, and you start grieving the future you thought you'd have. It's like, that's not going to happen now.'
Despite the heartbreak of learning she has ALS, Thompson acknowledged that she received her diagnosis relatively quickly.
Dr. Lorne Zinman, head of Sunnybrook Hospital's ALS Clinic in Toronto agreed.
Most family doctors will encounter only one or two ALS cases in their entire careerDr. Lorne Zinman
'In Canada, it typically takes patients one and a half to two years from their first symptom to receive a diagnosis,' he explained in a separate interview with Yahoo Canada.
One reason for the delayed diagnosis is that ALS has no 'diagnostic biomarkers' and a diagnosis is made 'ruling out every other possibility.
Adding to the challenge is the disease's rarity. ALS affects only two to three people per 100,000 annually, and there's a lack of awareness among general practitioners.
View this post on Instagram
A post shared by Stephanie Thompson (@alsgetsonmynerves)
'Most family doctors will encounter only one or two ALS cases in their entire career,' says Zinman. 'Stroke, by comparison, is far more common."
ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder. It destroys the nerve cells that control muscles, severely impairing speech, swallowing, movement, and eventually breathing. Unfortunately, today, there is no cure. Approximately 3,000 people in Canada are diagnosed with ALS each year; one thousand Canadians die annually from the disease.
The life expectancy for people with ALS varies, however Health Canada reports that 80 per cent of people die two to five years after their diagnosis.
'For reasons we don't fully understand, yet, the nerves controlling muscles begin to degenerate,' said Zinman. 'In most patients, the disease starts in one region of the body. If it begins with speech or swallowing, it's called bulbar-onset ALS; if it starts in the arms or legs, it's known as spinal-onset ALS.'
Living with ALS comes with a huge financial burden, something that Thompson and her fiancé Devin Duquette, have learned first-hand. They purchased a home in July 2023, seven months before Thompson received her diagnosis.
'Unfortunately, we did not get insurance on the mortgage. That was a financial hit for us because we have to maintain that mortgage throughout this process,' explained Thompson. In addition, the new home required upgrades such as the chair lift to help keep her as mobile as possible.
Since the pandemic, Thompson had been working remotely for a corporate bank. Although the job wasn't physically demanding, she ultimately had to stop working.
'I came to the point where the physical requirement to even be at a desk for that long was something that I couldn't do," she said. "Because of the continuous typing, I'll cramp up my hands. And then there was the stress of work and [after the diagnosis] the stress of [learning that] I'm dying.'
Despite the public health care system and provincial home care programs that offer some support, coverage is inconsistent across Canada. Families must grapple with the expensive treatments and out-of-pocket costs of medicines and specialized equipment that could provide comfort and care.
The ALS Society of Canada says the average financial burden a household incurs with a member living with ALS between $150,000 and $250,000 over the course of the disease. It's considered the "bankruptcy disease" because the yearly cost of ALS care is much higher than that for people living with HIV/AIDS, stroke survivors in their first year, or those with Alzheimer's.
With a reduced income, keeping up with everything is challengingStephanie Thompson
Although Thompson received help from the ALS Society of Canada, she and Duquette turned to GoFundMe to help raise money for bedroom equipment
'With a reduced income, keeping up with everything is challenging. The ALS Society of Canada provides some devices and equipment, but you don't have a say in what you receive. For example, I had to pay out of pocket for specific bathroom equipment,' she said.
View this post on Instagram
A post shared by Stephanie Thompson (@alsgetsonmynerves)
As per the ALS Society of Canada, the direct costs associated with ALS (including medical expenses, mobility aids, home modifications, and specialized services) on average add up to $32,337 per year, with families paying about 61 per cent of that — approximately $19,574 — out of pocket. Indirect costs, which are a result of loss of job or unpaid caregiving responsibility are an approximately an additional $56,821 annually.
Private insurance has been crucial in covering ALS-related expenses.
'Critical illness insurance helped with some costs, and the Assistive Devices Program will partially cover a specialized electric chair— which costs as much as a car— but I'll have to cover the rest,' she said.
Thompson has also turned to social media for support. In addition to her GoFundMe page, she has an Amazon wish list that includes items like a hydration system for people with limited mobility and a hand splint to help straighten her fingers.
'I'm grateful to social media for connecting me with the community. If someone wants to help but can't donate directly, an Amazon wish list with a $30 item could be a way. I'm happy with whatever works for them,' said Thompson.
Social media is not only a way for Thompson to connect with the community but also raise awareness for ALS. She's documenting her ALS journey on Instagram through her handle ALS Gets On My Nerves.
The guilt of this is something that I'm still working through. I'm proud how of Devin and my kids have adapted into our new normal.Stephanie Thompson
'This happened [to me] for a reason and I'm going to make the most of it to spread awareness because there's never enough awareness," she said.
Amid the chaos, Thompson and Duquette got engaged on Dec 31, 2021.
'The future we thought we would have isn't there. To pivot and to become one of my caregivers has been inspiring to me. He has to carry the household plus take care of me,' she says. 'His workload has increased substantially and he does it out of love. It's not the future that I thought we would be having. But I can't control it. The guilt of this is something that I'm still working through. I'm proud how of Devin and my kids have adapted into our new normal.
'We had a few detours and side quests along the way but are planning on getting married this year. Creating memories and finding our own joy and happiness throughout this journey is our primary objective.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stock Movers: NVO, DAY, AAPL
Stock Movers: NVO, DAY, AAPL

Bloomberg

time16 minutes ago

  • Bloomberg

Stock Movers: NVO, DAY, AAPL

On this episode of Stock Movers: - Novo Nordisk (NVO) shares advanced after the drugmaker's weight-loss drug Wegovy received US approval to treat a serious form of liver disease. The US Food and Drug Administration's decision "could start to help shift the momentum for Novo following a more difficult start to the year," according to Evan David Seigerman, an analyst at BMO Capital Markets. - Dayforce (DAY) shares are higher on news Thoma Bravo is in talks to acquire human resources management software provider Dayforce Inc., according to people familiar with the matter. The buyout firm is planning to take the Minneapolis-based company private in a deal that could be announced as soon as the coming weeks, the people said. - Apple (APPL) shares are reacting to news Apple's Vision Pro headset isn't selling well for two reasons: its $3,499 price tag and a lack of sufficiently compelling features. That's according to a report from Bloomberg's Mark Gurman. There are other issues — like a limited array of custom applications, the device's weight and a cumbersome setup process.

Tainted Supplements, Troubled Transactions: Social Commerce Dangers
Tainted Supplements, Troubled Transactions: Social Commerce Dangers

Forbes

time16 minutes ago

  • Forbes

Tainted Supplements, Troubled Transactions: Social Commerce Dangers

Rochelle Blease is the president of G2 Risk Solutions, a global risk management firm. Promising easy weight loss or an enhanced appearance, influencers are driving more traffic to nutraceutical websites that sell unapproved products. The strategy works; 77% of consumers prefer influencer content over ads. In a 2025 survey, 20% of U.S. adults reported buying based on influencer recommendations, and 43% follow at least one content creator. Beyond consumers, payment providers are also at risk. When health is at stake, regulators and card networks scrutinize sellers and the financial services that enable them. Payment providers often lack visibility into noncompliant merchant activity. That's because traditional due diligence wasn't built for today's high-velocity social commerce, where shoppable posts and affiliate links blur the line between content and commerce. In the U.S. alone, social commerce sales are projected to exceed $100 billion in 2026. Invisible Ingredients Social media fosters diet and beauty trends that often promote unsafe products. In 2024, for example, the FDA issued warnings about online sales of tainted weight loss supplements. Marketed as the Mexican fruit 'tejocote,' the products were found by the FDA to contain toxic yellow oleander, which can cause severe or fatal health effects. Tainted cosmetics are another area of concern. Through compelling visual content of before-and-after skin transformations, consumers can be guided to purchase potentially dangerous skincare. In recent years, regulators have uncovered products marketed as over-the-counter 'skin lighteners' that contain undisclosed ingredients, including hydroquinone and mercury. Consumers exposed to these products have experienced mercury poisoning, rashes and permanent skin discoloration. These examples represent a fraction of the murky world of social commerce, where every regulatory alert is a red flag that payment providers can't ignore. Payment Providers' Responsibility Viral trends and influencer endorsements introduce a highly dynamic risk vector into the payments industry. Payment providers are expected to vet and monitor their merchants for risky behaviors, including the sale of tainted supplements. In the view of card networks and regulators, facilitating payments ultimately helps dangerous merchants—even if the provider isn't aware of a merchant's illicit actions. Obtaining such awareness can be tricky. Merchants that look benign may be selling violative or illegal products that pose health dangers. Some merchants go to great lengths to hide the true nature of their businesses, using fake shell sites to pass due diligence checks. Others may leave vital information off their payment account applications, such as affiliated social commerce sites, sales pages or merchant category codes that would place them in high-risk categories. A single viral post can trigger thousands of transactions, making visibility gaps costly for payment providers. Card networks can impose significant fines for enabling illicit transactions. What's more, card network action often prompts additional scrutiny from regulators. Managing Merchant Risk To mitigate risks, payment providers need a responsive framework that includes deeper onboarding intelligence and continuous monitoring. A programmatic, data-driven approach can surface red flags. Here are five actionable steps payment providers should take: Traditional underwriting is not enough in a market where a merchant can shift product lines, ownership or marketing tactics in a matter of hours. Acquiring banks should expand initial due diligence to include beneficial ownership verification, adverse media screening and website traffic analysis. More importantly, they should adopt a scheduled refresh process to keep that data current. Doing so can help spot risk indicators before they turn into enforcement actions. In an industry where reputational fallout travels faster than compliance updates, reactive vetting is no longer defensible. Once a merchant is onboarded, too many acquirers rely solely on transaction data to spot fraud. That's no longer enough. The front end of many risky supplement sellers is a slick landing page optimized for conversion—one that may change copy, imagery and claims overnight. By incorporating automated web-crawling, payment providers can quickly flag risky language like 'FDA-approved' or 'clinically proven.' When a supplement merchant updates its marketing to include aggressive health claims, it's often a sign of accelerating risk. Banks are not labs and shouldn't try to act like them. However, they can make powerful use of existing regulatory data. Government agencies issue a steady stream of alerts, many of which are specific to product brands, ingredients and merchant URLs. By ingesting and cross-referencing this data against their own merchant portfolio, payment providers can quickly flag when a merchant is under regulatory scrutiny. It's a simple but often overlooked method for maintaining awareness of known bad actors—one that doesn't require waiting for a spike in chargebacks to signal trouble. Payment providers have one data stream that regulators and card networks don't: real-time transaction trends. Used correctly, that stream becomes a powerful source of early detection. Unusual spikes in high-ticket transactions, increases in cross-border routing or refund patterns that don't match the merchant's stated model are signs that something may be amiss. Sophisticated acquirers are now using AI-assisted tools to benchmark merchants against known fraud patterns, surfacing anomalies before they become liabilities. When violations do occur—whether flagged internally or raised by a network—speed and structure matter. Leading risk teams are developing standardized systems that capture digital evidence (like screenshots, product descriptions and influencer endorsements) and route that data through tiered workflows. Depending on the severity of the issue, these may trigger outreach for clarification, a corrective action plan or merchant termination. Crucially, this approach generates an audit trail that demonstrates to networks or regulators that the bank took reasonable and timely steps. In today's climate, that paper trail can mean the difference between resolving an issue and becoming part of an enforcement action. The Path Forward: Coordinated Intelligence, Not Just Controls Modern risk management is no longer rooted in static compliance. It's driven by real-time intelligence strategies that surface red flags quickly. The opportunity lies in integration: Connecting onboarding, monitoring, regulatory data and transaction signals into a unified view of merchant behavior. Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?

UBS upgrades CVS, says turnaround in health benefits business gaining traction
UBS upgrades CVS, says turnaround in health benefits business gaining traction

Yahoo

time43 minutes ago

  • Yahoo

UBS upgrades CVS, says turnaround in health benefits business gaining traction

-- UBS upgraded CVS Health (NYSE:CVS) to Buy from Neutral and raised its price target to $79, saying recent cost controls and execution in the company's healthcare benefits arm are beginning to show results and the improvement is not yet priced into the stock. The brokerage said CVS has posted two consecutive quarters of stronger-than-expected results, helped by better forecasting of Medicare Advantage utilization and early signs that fixes to its underperforming group insurance segment are working. UBS now expects CVS earnings to grow at a 14% compound annual rate through 2028, above its previous forecast and the Street's estimated 12%. Analysts pointed to CVS correctly cutting benefits and recalibrating assumptions in its Medicare Advantage plans for this year, leading to a more stable claims trend and meaningful reserve release. They estimate the group Medicare Advantage business, where roughly half of contracts are being repriced in 2025, could move from negative mid-to-high single-digit margins to positive territory, contributing an estimated $0.46 per share in 2026 earnings. UBS also expects CVS to return to roughly 3.5x leverage by late 2026, creating room for share buybacks and further earnings growth. At around nine times 2026 earnings, the stock trades below its long-term historical average of 10 times, despite a reaccelerating growth profile. Risks include potential deterioration in Medicare Star quality ratings in October, and pending U.S. regulation on drug pricing or pharmacy-benefit managers. But UBS said CVS remains confident in its Stars positioning, noting that about 65% of plan members are in contracts rated 4.5 stars or higher well above the bonus threshold. Related articles UBS upgrades CVS, says turnaround in health benefits business gaining traction Bernstein upgrades Toyota stock as journey to 20% RoE kicks off AI could deliver $920B in annual net benefits to S&P 500 firms Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store